rs6681346
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_007357.3(COG2):c.912T>A(p.Asn304Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0272 in 1,609,674 control chromosomes in the GnomAD database, including 2,181 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_007357.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COG2 | NM_007357.3 | c.912T>A | p.Asn304Lys | missense_variant | 9/18 | ENST00000366669.9 | NP_031383.1 | |
COG2 | NM_001145036.2 | c.912T>A | p.Asn304Lys | missense_variant | 9/18 | NP_001138508.1 | ||
COG2 | XM_047449445.1 | c.573T>A | p.Asn191Lys | missense_variant | 7/16 | XP_047305401.1 | ||
LOC107985358 | XR_001738517.1 | n.289A>T | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COG2 | ENST00000366669.9 | c.912T>A | p.Asn304Lys | missense_variant | 9/18 | 1 | NM_007357.3 | ENSP00000355629.4 |
Frequencies
GnomAD3 genomes AF: 0.0679 AC: 10334AN: 152126Hom.: 821 Cov.: 32
GnomAD3 exomes AF: 0.0390 AC: 9687AN: 248074Hom.: 592 AF XY: 0.0390 AC XY: 5228AN XY: 134100
GnomAD4 exome AF: 0.0230 AC: 33477AN: 1457430Hom.: 1360 Cov.: 30 AF XY: 0.0245 AC XY: 17742AN XY: 724890
GnomAD4 genome AF: 0.0680 AC: 10356AN: 152244Hom.: 821 Cov.: 32 AF XY: 0.0688 AC XY: 5126AN XY: 74452
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 10, 2019 | - - |
Congenital disorder of glycosylation, type IIq Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at